Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes
Cannabis use is increasing with the shifts in legality and public perceptions in the United States. In adults with T1D, cannabis use within the previous 12 months was associated with an increased risk of DKA compared with no cannabis use (entire cohort OR, 1.98; 95% CI, 1.01-3.91) ( Table 2) . Compared with nonusers with T1D, the mean (SD) HbA 1c level (8.4% [2.0%] vs 7.6% [1.6%], P < .01) was higher but there was no difference in severe hypoglycemia (21 of 134 [15.6%] vs 64 of 316 [20.3%], P = .17) among cannabis users with T1D. Cannabis users had a mean 0.41% higher HbA 1c level than nonusers when adjusted for insulin delivery method, income, and age (β, 0.41; 95% CI, 0.38-0.43).
Discussion | In the present survey study, the prevalence of cannabis use was 30% among adults with T1D. Cannabis use was associated with a higher risk for DKA in this population. Cannabinoids alter gut motility and cause hyperemesis, which may play a role in increased risk for DKA in T1D. 4, 6 A small sample size, single-center, and self-reported diabetes outcomes are limitations of the present study. The possibility of unmeasured confounders, such as access to health care, cannot be excluded. Further research is needed to confirm these findings and understand the effects and adverse consequences of cannabis use in patients with T1D. f Cannabis use frequency was derived from CUDIT-R questionnaire.
